Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile. (Q35199060)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292853%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292853%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

main subject

Clostridium difficile

0 references

author

Franz Allerberger

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292853%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Steliana Huhulescu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292853%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Ulrich Sagel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292853%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Anita Fiedler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292853%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Verena Pecavar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292853%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Marion Blaschitz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292853%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Guenther Wewalka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292853%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Alexander Indra

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292853%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

3 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292853%20AND%20SRC:MED&resulttype=core&format=json

Journal of Medical Microbiology

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292853%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292853%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

Pt 8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292853%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

1206-1212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292853%20AND%20SRC:MED&resulttype=core&format=json

Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping.

21 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167878

Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167878

Setting and revising antibacterial susceptibility breakpoints

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167878

Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167878

Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167878

PCR-restriction fragment length polymorphism analysis for identification of Bacteroides spp. and characterization of nitroimidazole resistance genes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167878

In vitro activity and fecal concentration of rifaximin after oral administration

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167878

Deletions in the repeating sequences of the toxin A gene of toxin A-negative, toxin B-positive Clostridium difficile strains

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167878

Clinical impact of rapid in vitro susceptibility testing and bacterial identification

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167878

In vitro antibacterial activity of rifaximin against Clostridium difficile, Campylobacter jejunii and Yersinia spp.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167878

Identification of toxigenic Clostridium difficile by the polymerase chain reaction.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167878

Treatment of hepatic encephalopathy with non-absorbable antibiotics

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167878

In vitro susceptibility of Clostridium difficile to rifaximin and rifampin in 359 consecutive isolates at a university hospital in Houston, Texas

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167878

Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167878

Treatment of small intestine bacterial overgrowth with rifaximin, a non-absorbable rifamycin

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21292853

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Interruption of Recurrent Clostridium difficile-Associated Diarrhea Episodes by Serial Therapy with Vancomycin and Rifaximin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21292853

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1099/JMM.0.028571-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292853%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21292853%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

PubMed publication ID

21292853

1 reference